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Immunity and Effectors Are BAK !
Plants use the same set of co-receptors to mediate distinct responses to
external signals. Brassinosteroid signaling serves as a test case to unravel the
mechanisms of receptor–co-receptor activation and initiation of a specific
signaling cascade.
Gre´gory Vert
Plant growth and development are
driven by a complex network of internal
signals, including brassinosteroids
(BRs), the polyhydroxylated steroid
hormones of plants. Over the past
decade, genetic and biochemical
approaches have provided a wealth of
information on BR perception and
signaling, but the precise molecular
mechanisms driving receptor complex
activation and signal transduction to
downstream ‘actors’ are still not fully
understood [1]. Recent reports have
elucidated how BR perception leads to
sequential activation of the receptor–
co-receptor complex and have
identified new BR signaling
components acting directly
downstream of the receptor.
Unlike animal steroid hormones,
which are mostly perceived by the
nuclear receptor family of transcription
factors, BRs bind directly to the
extracellular domain of BRI1,
a leucine-rich repeat receptor-like
kinase (LRR-RLK) that is localized
to the plasma membrane [2]. Binding
of BRs to pre-existing BRI1
homo-oligomers leads to BRI1
autophosphorylation and to
transphosphorylation of the LRR-RLK
BAK1/SERK3 [3–6]. Unexpectedly,
BAK1, together with other homologs
of the SERK subfamily, was recently
shown to regulate cell death and to
function in multiple pathogen-
associated molecular pattern (PAMP)
responses, including responses to
flagellin, EF-Tu, bacterial cold-shock
protein, and oomycete elicitor INF1,
that serve as the first line of defense
against pathogens [7–10]. Analogous
to its interaction with BRI1, BAK1 was
shown to rapidly associate with the
LRR-RLK flagellin-binding receptor
FLS2 shortly after ligand stimulation [7].
However, BAK1 binds neither BRs nor
flagellin [6,7]. Instead, BAK1 appears
to act as a general co-receptor of the
main ligand-binding receptor, together
likely forming a signaling-competent
hetero-oligomer. Interestingly, BAK1
has also been shown to promote BRI1
and FLS2 internalization into
endosomes [11,12], reminiscent of
ligand-induced activation,
multimerization and internalization of
animal single-pass transmembrane
receptors. Therefore, it is unclear
whether BAK1’s main function is to
activate the ligand-binding receptor,
to bridge the receptor with
downstream components, or to
promote receptor endocytosis.
To crack the code of BR receptor
complex activation, Wang and
colleagues [13] thoroughly dissected,
in vitro and in vivo, the sequential
mechanisms leading to BRI1 and BAK1
phosphorylation, and how differential
receptor activation correlates with
signaling. This interesting study
revealed that BRI1 acts independently
of its co-receptor BAK1 to bind its
ligand, to initiate kinase activation and
to sustain basal BR signaling and
responses, as visualized by the
elongation of the hypocotyl (the plant
embryonic stem). However, full BR
responses arise from the association
between activated BRI1 and BAK1
and subsequent transphosphorylation
of BAK1’s activation loop residues.
Activated BAK1, in turn,
transphosphorylates BRI1 in the
juxtamembrane and carboxy-terminal
domains, leading to enhanced BRI1
kinase activity and BR signaling
(Figure 1A). More importantly, the
authors provide the first framework
for grasping how differential
phosphorylation of BAK1 by
associated ligand-binding receptor
kinases likely explains its participation
in different signaling pathways.
Notably, BAK1 residue T450 is
phosphorylated by BRI1 in vitro and,
presumably, in vivo, but mutation of
the corresponding residue does not
affect the various BAK1-dependent
signaling pathways to the same
extent. Indeed, phenotypic analysis
of plants expressing a T450A
non-phosphorylatable BAK1 mutant
version revealed that phosphorylation
at this BAK1 residue may be
important to activate BRI1 and
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required for cell death regulation. A
comparative analysis of BAK1 in vivo
phosphorylation sites in BR versus
flagellin-treated plants is needed
to shed additional light on the
phosphorylated residues leading to
differential BAK1 activation by BRI1
and FLS2 and, in turn, on the role of
BAK1 in the subsequent activation
of different LRR-RLKs.
Does BAK1 have other roles besides
just activating the ligand-binding
receptor? How about the role of BAK1
in receptor endocytosis? One would
expect to observe ligand-dependent
receptor endocytosis considering that
BAK1 associates with the main
receptor upon ligand binding. While
this scenario fits well with the data
obtained for FLS2 [7,11], a recent study
elegantly demonstrated that BRI1 is
endocytosed in a BR-independent
manner [14]. Further conclusions on
the role of BAK1 in endocytosis of BRI1
will await a detailed analysis of BRI1
internalization in bak1 mutant plants.
As part of the receptor complex,
can activated BAK1 signal to
downstream components? Probably
not in the case of BR signaling,
considering that overexpression of
BAK1 is unable to suppress strong
bri1 alleles [3,4], although
overexpression of an ‘activated’ form
of BAK1 containing phosphomimetic
mutations at sites phosphorylated by
BRI1 may be more conclusive.
Moreover, no overlap between
responses induced by BR and flagellin
exist. Finally, no BAK1-interacting
proteins acting downstream of BRI1
and FLS2 receptors in the
corresponding signaling pathways
have been reported. This supports
the notion that BAK1 solely functions
in receptor activation, leaving the
signaling to the ligand-binding
receptor.
Despite extensive genetic screens
looking for BR-related mutants, a major
gap remains between BR perception
and downstream events in the
signaling cascade, such as the
inactivation of the BIN2 GSK3 kinase
[1]. Why is this so? From these past
unsuccessful attempts we can deduce
that the relevant genes are either
functionally redundant or that the loss
of their functions results in lethality.
Searches for BRI1-interacting proteins
have identified several potential actors,
although their in vivo role in BR
signaling is not well understood. Only
the BRI1-kinase interactor BKI1 has
been shown to limit BRI1 and BAK1
interaction to prevent receptor
activation in the absence of BRs [15]. In
a recent report, Tang and colleagues
[16] identified the BSK receptor-like
cytosolic kinases as new BRI1
substrates. BSK1 interacts in vivo with
plasma-membrane-localized BRI1,
with BRs decreasing their association
(Figure 1A). Loss- and gain-of-function
genetic analyses of some BSK
family members suggest that they
are positive regulators of BR signaling,
acting upstream of BIN2. A model
emerges in which BSKs might be
released from the receptor upon
phosphorylation by BRI1 to transduce
the signal to downstream components.
Again, BAK1 turns out to be unable
to interact with BSKs, further
supporting the hypothesis that BR
signaling to downstream actors
initiates from BRI1. Whether BIN2,
whose plasma membrane localization
has already been documented [17], is
a substrate of BSK kinase activity
remains an open question in this
‘grail quest’ for the missing
downstream factors.
While the puzzle of the core BR
signaling cascade rapidly assembles,
its interaction with other pathways has



















































Figure 1. BAK1-dependent signaling pathways.
(A) Brassinosteroid (BR) perception by BRI1 triggers its autophosphorylation (P) and phos-
phorylation-dependent release of BKI1 and BSK proteins from the receptor, allowing basal
signal transduction by BSKs to downstream factors and association of BRI1 with BAK1. Trans-
phosphorylation of BAK1 leads, in turn, to full activation of BRI1 by further BRI1 phosphory-
lation and promotes enhanced BR responses. (B) P. syringae injects into the cell the AvrPto
and AvrPtoB effectors, which bind to BAK1 and prevent its flagellin-dependent association
with FLS2 and other pattern recognition receptors (PRRs), leading to PAMP-triggered immu-
nity (PTI) suppression. Other BAK1-dependent pathways, such as BR signaling and cell death,
are also affected.
Cognitive Neuroscience: Searching
for the Bottleneck in the Brain
People simply cannot do two things at once, as shown by research on the
so-called psychological refractory period. A new neuroimaging study has now
localized the response-selection bottleneck underlying the psychological
refractory period to a frontoparietal network.
Charles Spence
The notion that dual-task performance
in humans is fundamentally
constrained by some kind of internal
bottleneck goes back more than half
a century to the pioneering early work
of Kenneth Craik, Alan Welford, and
Margaret Vince [1,2]. In recent years,
most research on this topic has been
conducted within the framework of the
‘psychological refractory period’ — the
interference (or delay) in responding
to the second of two stimuli that is
observed when they are presented
close together in time. Hal Pashler
and his colleagues [3,4] have published
an impressive number of behavioral
studies on the psychological refractory
period showing, time-and-again, that
people simply cannot perform two
tasks at once, no matter how much
Dispatch
R965and defense signaling pathways share
BAK1 [3,4,7,9], but recent work from
Shan and colleagues [18] provides
evidence that some bacterial effectors
strike back at PAMP-triggered
immunity (PTI) by targeting BAK1.
Effectors are usually injected into plant
cells by successful bacteria upon
infection to evade recognition or to
suppress the subsequent signaling
steps. Previous work revealed that
AvrPto and AvrPtoB, two unrelated
effectors from Pseudomonas syringae
DC3000, target early steps in various
PAMP signaling pathways, apparently
upstream of a MAP kinase cascade
important for PTI [19]. Shan et al. [18]
now report that both effectors bind
in vivo with high affinity to BAK1,
and prevent its ligand-dependent
interaction with FLS2. Moreover,
artificial overexpression of AvrPto and
AvrPtoB in transgenic Arabidopsis
leads to BR-related dwarfism, likely
resulting from BAK1’s inability to
associate with BRI1 (Figure 1B). This
interesting observation will have to
be confirmed using natural levels of
bacterial-delivered effectors to
evaluate if BR signaling is actually
downregulated upon infection with
P. syringae. If this scenario holds true,
could inhibition of BR signaling be
thought of as collateral damage in
this war between plants and their
pathogens? Do bacterial effectors
intentionally target BR-mediated
growth or pathogen resistance, which
BRs have been linked to [20]? The
rationale for disabling a general
co-receptor and interfering with
several BAK1-dependent pathways is
not clear yet. One can imagine that
bacteria manipulate several PTI
responses, including BR signaling and
cell death, to increase pathogenicity
and to team up with other pathogens
to overwhelm plant defenses.
Future studies should provide a new
basis for understanding how BR
signaling is interconnected with other
pathways, and why different signaling
cascades co-opted the same
co-receptor to mediate complex
and specific responses.
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